AzTrials
AzTrials

AdhdNCT04180189

An Intervention With Weighted Blankets for Children With ADHD and Sleep Problems

A study testing Weighted fiber blanket in people with Adhd and Sleep Disturbance, run by Halmstad University at 1 site in Sweden.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of the study is to evaluate a sleep intervention with weighted blankets for children with ADHD and sleep problem regarding health-related outcomes, sleep, and cost-effectiveness. The study is an RCT with cross-over design. Read more about this study

Who is it for?
Ages 6 to 13 years
Conditions the study is for
Adhd, Sleep Disturbance
What is being tested?
Weighted fiber blanket
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
100 participants
Where
1 siteSweden
Study dates
1 Jan 2020to 30 Jun 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 to 13 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Children diagnosed with ADHD with sleep problems (defined by screening instrument). -
  • Being a patient at child and adolescent mental health service (CAMHS) in Region Halland, Sweden.
  • Parents and children should understand (written and spoken) Swedish language.

Who cannot join

  • Already used weighted blankets as a sleep intervention,
  • If they have received a new prescription or change of pharmacological treatment for sleep problems

Trial locations and contacts

1 site in 1 country.

Sweden1 site
  • Halmstad University

    Halmstad, 30118

Other trials in Sweden

About this study

Official title: SLEEP - An Intervention With Weighted Blankets for Children With Attention Deficit Hyperactivity Disorder (ADHD) and Sleep Problems

The aim of the study is to evaluate a sleep intervention with weighted blankets for children with ADHD and sleep problem regarding health-related outcomes, sleep, and cost-effectiveness.

The study is an RCT with cross-over design. The participants will be randomized to start with an active or placebo blanket, and then change blankets during the 16 week study period.

Read the detailed description

There is limited evidence about health outcomes or health-economic benefits of sleep interventions with weighted blankets for children with neuropsychiatric syndromes (NPS).

The aim of the study is to evaluate a sleep intervention with weighted blankets for children with ADHD and sleep problem regarding health-related outcomes, sleep, and cost-effectiveness.

The participants, n=100 children between 6 and 13 years old, will be recruited from the ADHD unit in Child and Adolescent Mental Health Service (CAMHS) and randomly assigned into two groups: Fiber Weighted Blankets (intervention 1) and Control Blankets (controls).

The children will use each blanket respectively for 4 weeks, then change blankets. A long term follow-up will be conducted 16 weeks from baseline.

Being tested
Weighted fiber blanket
Keywords
children, non-pharmacological intervention, ADHD, sleep
Medical subject headings
Attention Deficit Disorder with Hyperactivity, Parasomnias

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Weighted fiber blanketOther

    Using weighted blanket for four weeks

Study groups in NCT04180189
Study groupRoleWhat they receive
Weighted fiber blanketActive comparatorUsing a weighted blanket
Receives: Other: Weighted fiber blanket
Regular fiber blanketPlacebo comparatorUsing a specially designed fiber blanket without extra weight.
Receives: Other: Weighted fiber blanket

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Sleep efficiency

    objectively measured with actigraph during one week

    Measured: 1 week

  2. Sleep onset latency

    objectively measured with actigraph during one week

    Measured: 1 week

  3. Wake after sleep onset

    objectively measured with actigraph during one week

    Measured: 1 week

  4. Total sleep time

    objectively measured with actigraph during one week

    Measured: 1 week

  5. Self-reported sleep (Parental reported)

    Subjectively measured sleep problems in smaller children, assessed by Child's Sleep Habits Questionnaire (CSHQ), assessed by the parents, referring to last week. consists of 33 items related to eight subscales; 1) Bedtime resistance, 2) Sleep onset delay, 3) Sleep duration, 4) Sleep anxiety, 5) Night wakings, 6) Parasomnias, 7) Sleep-disordered breathing, and 8) Daytime sleepiness. Each item is rated on a three-point scale: "usually" if the sleep behavior occurred five to seven times/week; "sometimes" for two to four times/week; and "rarely" for zero to one time/week. A higher score indicates more sleep problems

    Measured: 1 week

  6. Self-reported sleep

    Subjectively measured sleep problems in children, assessed by Insomnia Severity Index (ISI), children responding, referring to last week, comprises seven items for the children to respond to: 1) Severity of sleep-onset, 2) Sleep maintenance, 3) Early morning awakening, 4) Satisfaction with current sleep pattern, 5) Interference with daily functioning, 6) Noticeability of impairment attributed to the sleep problem, and 7) Level of distress caused by the sleep problem. Each item is rated on a five-point Likert scale ranging from "not at all" (scored at 0) to "extremely" (scored at 4). Total score ranges from 0 to 28, with higher scores indicating greater severity.

    Measured: 1 week

Secondary outcomes (8)
  1. Parents' Health related quality of life

    Assessed by EQ5D (among the parents), referring to this day. measuring the parents' health comprising five dimensions; 1) Mobility, 2) Self-care, 3) Usual activities, 4) Pain/discomfort, and 5) Anxiety/Depression. Each dimension is divided into three levels; No problems, Some or moderate problems, and extreme problems. In addition to the five dimensions, a 100-millimeter vertical Visual Analog Scale with endpoints of 100 means "best imaginable health state" and 0 means "worst imaginable health state is included. The total score ranges from 0 to 1 where a higher score indicates a better health-related quality of life.

    Measured: 1 day

  2. Children's Health related quality of life

    Assessed by EQ5D-y (among the children), referring to this day, comprises five items; 1) Walking about (mobility), 2) Looking after myself (self-care), 3) Doing usual activities (usual activities), 4) Having pain or discomfort (pain and discomfort), and 5) Feeling worried, sad or unhappy (anxiety and depression). Each item is divided into three levels; No problems, Some problems, and A lot of problems. The EQ-5D-Y also includes an easily understandable modified vertical Visual Analogue Scale of EQ-5D, where the respondent rates the overall health status with the endpoints from 0 (the worst health state the child can imagine and 100 (the best health state the child can imagine)

    Measured: 1 day

  3. Children's general well-being

    Assessed by Child Outcome Rating Scale (CORS), among the children, comprises four items where the child evaluates; 1) Me (How am I doing?), 2) Family (How are things in my family?), 3) School (How am I doing at school?), 4) Everything (How is everything going?). Each item is rated on a 100-millimeter Visual Analog Scale with smiling and sad faces as anchors.

    Measured: 1 day

  4. Parent general well-being

    Assessed by Outcome Rating Scale (ORS), among the parents assessment of the past week in four items; 1) Personal wellbeing, 2) Interpersonal relationships, 3) Social relations and, 4) Overall sense of well-being. Each item is rated on a 100-millimeter Visual Analog Scale with anchors from 0 (negative) to 100 (positive).

    Measured: 1 day

  5. Anxiety

    Assessed by short State-Trait Anxiety Inventory for children (short-STAI), includes six items.41 Each item is rated on a four-point Likert scale ranging with 1 = "not at all," 2 = "somewhat," 3, = "moderately", and 4 = "very much." The total score range from 6 to 24 points, with 6 points indicating no anxiety and 24 points indicating the highest level of anxiety.

    Measured: 1 day

  6. ADHD symptoms

    Assessed by The Swanson, Peland, and Nolan Scale (SNAP-IV), consists of 30 items and is divided into three subscales: inattention (nine items), hyperactivity/impulsivity (nine items), and oppositionality (eight items) and four supplementary questions regarding oppositionality (two questions) and ADHD (two questions). Items are rated on a four-point Likert scale range 0 = "not at all", 1 = "just a little", 2 = "quite a bit", and 3 = "very much". Items for inattention and hyperactivity/impulsivity can be combined to create a "combined ADHD" score.43 Higher scores represent more symptoms.

    Measured: 1 week

  7. Family situation and parental mood

    Assessed by Brief Child and Family Phone Interview (BCFPI), consists of 36 symptom items and another 36 items to assess function, adversity, and family stress grouped into 12 subscales. The subscale ´family situation' contains three items rated on a four-point Likert scale range 1 = never, 2 = sometimes, 3 = often, 4 =always. The subscale ´parental mood' contains six items based on the question "How often during the past week has the parent experienced…?" rated on a four-point scale; < 1 day, 1-2 days, 3-4 days, >5 days.

    Measured: 1 week

  8. Cost effectiveness

    Assessed by health economic aspects, such as absence from work, productivity, contact with health-care last four weeks

    Measured: 4 week

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Nov 2019
  2. Study start1 Jan 2020
  3. Primary completion30 Jun 2022
  4. Study completion30 Jun 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Masking
Double blind
Who is masked
Participant, Care provider
Enrolment
100 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04180189
Sponsor's protocol ID
1SLEEP
Status last verified
Feb 2023
First submitted
21 Nov 2019
Last updated
1 Mar 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Larsson I, Aili K, Nygren JM, Johansson P, Jarbin H, Svedberg P. SLEEP: intervention with weighted blankets for children with attention deficit hyperactivity disorder (ADHD) and sleep problems: study protocol for a randomised control trial. BMJ Open. 2022 Jan 4;12(1):e047509. doi: 10.1136/bmjopen-2020-047509.

    PubMed 34983749

Questions about this trial

What is this clinical trial studying?

A study testing Weighted fiber blanket in people with Adhd and Sleep Disturbance, run by Halmstad University at 1 site in Sweden.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 1 Mar 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Sleep efficiency (time frame: 1 week). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04180189, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Mar 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in